Accession Number: | 0001104659-20-078229 |
Date: | 2020-06-25 |
Issuer: | MERSANA THERAPEUTICS, INC. (MRSN) |
Original Submission Date: |
ALLEVA LAWRENCE M
C/O MERSANA THERAPEUTICS, INC.
840 MEMORIAL DRIVE
CAMBRIDGE, MA 02139
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 22.9 | 2020-06-25 | deemed execution date | A | 9,200 (a) | 2030-06-25 | common stock 9,200 | $22.90 | 9,200 | direct |
ID | footnote |
---|---|
f1 | the option vests in full on the earlier of the first anniversary of the date of grant or the date of the 2021 annual meeting of stockholders of mersana therapeutics, inc. |